Sorafenib Cardiotoxicity Increases Mortality after Myocardial Infarction

RATIONALE: Sorafenib is an effective treatment for renal cell carcinoma, but recent clinical reports have documented its cardiotoxicity through an unknown mechanism. OBJECTIVE: Determining the mechanism of sorafenib-mediated cardiotoxicity. METHODS AND RESULTS: Mice treated with sorafenib or vehicle...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Duran, Jason M., Makarewich, Catherine A., Trappanese, Danielle, Gross, Polina, Husain, Sharmeen, Dunn, Jonathan, Lal, Hind, Sharp, Thomas E., Starosta, Timothy, Vagnozzi, Ronald J., Berretta, Remus M., Barbe, Mary, Yu, Daohai, Gao, Erhe, Kubo, Hajime, Force, Thomas, Houser, Steven R
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4037647/
https://ncbi.nlm.nih.gov/pubmed/24718482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.114.303200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados